Investors were disappointed by the electric vehicle manufacturer's production update for the first quarter.
The bank's first-quarter profit was boosted by the higher interest rate.
The first-quarter earnings of the investment firm beat analyst expectations.
The biopharmaceutical firm gave investors a disappointing update on regulatory issues.
The bank's financial performance in the first quarter was better than Wall Street's expectations.